B
Market Data
$171.59−$3.23 (−1.85%)
BIIB · Last trade
Prev Close
$174.82
Range (30d)
$164.42 – $187.62
Recent Filings
- 8-K202.1 KBBIOGEN INC.Jan 13, 5:38 PM ET·0000875045-26-000003
- 10-Q17.5 MBBIOGEN INC.Oct 30, 6:31 AM ET·0000875045-25-000049
- 8-K770.3 KBBIOGEN INC.Oct 30, 6:13 AM ET·0000875045-25-000047
- 8-K205.7 KBBIOGEN INC.Oct 14, 4:19 PM ET·0000875045-25-000040
- 8-K739.1 KBBIOGEN INC.Jul 31, 6:13 AM ET·0000875045-25-000035
- 10-Q16.9 MBBIOGEN INC.Jul 31, 6:05 AM ET·0000875045-25-000033
- SCHEDULE 13D/A7.3 KBSage Therapeutics, Inc.Jul 30, 5:56 PM ET·0000950157-25-000596
- SCHEDULE 13D/A9.6 KBSage Therapeutics, Inc.Jul 21, 9:18 PM ET·0000950157-25-000586
- 8-K205.7 KBBIOGEN INC.Jul 7, 4:10 PM ET·0000875045-25-000027
- 8-K234.5 KBBIOGEN INC.Jun 23, 4:18 PM ET·0000875045-25-000023
Insiders
10- ADELMAN BURT AEVP, Portfolio Strategy
- ALEXANDER SUSAN HEVP, General Counsel
- BELZER ALANDirector
- BEST LAWRENCE CDirector
- BUCKNUM THOMAS JEVP and General Counsel
- CAPELLO JEFFREY DEVP & Chief Financial Officer
- Clancy Paul JExecutive VP and CFO
- COVINO GREGORY FVP, Chief Accounting Officer
- Cox JohnEVP Pharmaceutical Oper & Tech
- DEKKERS MARIJN EDirector
Tickers
Addresses
business
225 BINNEY STREET
CAMBRIDGE, MA, 02142
mailing
225 BINNEY STREET
CAMBRIDGE, MA, 02142
Former Names
- BIOGEN IDEC INC.2015-03-20
- BIOGEN IDEC INC2007-04-25
- IDEC PHARMACEUTICALS CORP / DE2003-11-12
- IDEC PHARMACEUTICALS CORP / CA1997-02-14